Neurosurgical Strategies for Drug-Resistant Epilepsy
This session reviews Neurosurgical Strategies for Drug-Resistant Epilepsy and its most clinically relevant points for exam preparation and bedside decision-making.
Duration
00:02:19
File size
1.20 MB
Practitioner-Guided Note
For Neurosurgical Strategies for Drug-Resistant Epilepsy, use the highest-yield facts to drive concrete treatment decisions. Pay particular attention to Anterior temporal lobectomy: ~70% achieve seizure freedom (higher with visible lesion), Bilateral mesial resection: profound permanent anterograde amnesia risk, and Mesial temporal sclerosis: most common MTLE pathology when choosing therapy, counseling about risk, planning monitoring, and deciding when closer follow-up or escalation is needed.
Key Takeaways
Anterior temporal lobectomy: ~70% achieve seizure freedom (higher with visible lesion)Bilateral mesial resection: profound permanent anterograde amnesia riskMesial temporal sclerosis: most common MTLE pathologyCorpus callosotomy: palliative; effective for drop attacks/atonic seizuresSubpial transection: preserves vertical function in motor/speech cortex while disrupting horizontal seizure spread